Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study

MLA

G. Buonfanti, et al. Bone Effect of Adjuvant Tamoxifen, Letrozole or Letrozole plus Zoledronic Acid in Early-Stage Breast Cancer: The Randomized Phase 3 HOBOE Study. Jan. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5e36da332b666974bbc5593e0d069612&authtype=sso&custid=ns315887.

APA

G. Buonfanti, Ciro Gallo, A. De Matteis, Simona Signoriello, Vincenza Tinessa, Alessandro Morabito, F. Perrone, Mauro Piccirillo, Carmen Pacilio, Gennaro Daniele, E. De Maio, M. De Laurentiis, Roberta D’Aniello, G. Botti, Giuseppe Esposito, F. Di Rella, G. Landi, Elisa Rossi, Massimiliano D’Aiuto, … Francesco Nuzzo. (2012). Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study.

Chicago

G. Buonfanti, Ciro Gallo, A. De Matteis, Simona Signoriello, Vincenza Tinessa, Alessandro Morabito, F. Perrone, et al. 2012. “Bone Effect of Adjuvant Tamoxifen, Letrozole or Letrozole plus Zoledronic Acid in Early-Stage Breast Cancer: The Randomized Phase 3 HOBOE Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5e36da332b666974bbc5593e0d069612&authtype=sso&custid=ns315887.